KRT18 and metabolic dysfunction-associated steatohepatitis: Previous studies have reported that CK-18 achieves a sensitivity of 92.9% and specificity of 63% for MASH diagnosis [15], while FibroScan® has demonstrated a reliable accuracy in diagnosing significant fibrosis in PWH when compared with paired liver biopsies [16].